monoamine oxidase inhibitor


Also found in: Thesaurus, Medical, Acronyms, Encyclopedia, Wikipedia.
Related to monoamine oxidase inhibitor: SSRI, Selegiline, monoamine oxidase inhibitor diet

monoamine oxidase inhibitor

n. Abbr. MAOI
Any of a class of antidepressant drugs that block the action of monoamine oxidase in the brain, thereby allowing the accumulation of monoamine neurotransmitters such as norepinephrine and serotonin.
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.

monoamine oxidase inhibitor

n
(Biochemistry) biochem an agent that inhibits the action of monoamine oxidase. Such inhibitors are used in the treatment of depression. Abbreviation: MAOI
Collins English Dictionary – Complete and Unabridged, 12th Edition 2014 © HarperCollins Publishers 1991, 1994, 1998, 2000, 2003, 2006, 2007, 2009, 2011, 2014

mon′oamine′ ox′idase inhib`itor


n.
any of various substances that block enzymatic breakdown of certain monoamine neurotransmitters and that are used to treat depression. Abbr.: MAOI
[1960–65]
Random House Kernerman Webster's College Dictionary, © 2010 K Dictionaries Ltd. Copyright 2005, 1997, 1991 by Random House, Inc. All rights reserved.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.monoamine oxidase inhibitor - any of a group of antidepressant drugs that inhibit the action of monoamine oxidase in the brain and so allow monoamines to accumulatemonoamine oxidase inhibitor - any of a group of antidepressant drugs that inhibit the action of monoamine oxidase in the brain and so allow monoamines to accumulate
antidepressant, antidepressant drug - any of a class of drugs used to treat depression; often have undesirable side effects
iproclozide - an antidepressant drug that acts as a monoamine oxidase inhibitor
isocarboxazid, Marplan - a monoamine oxidase inhibitor (trade name Marplan) that is used to treat clinical depression
Nardil, phenelzine - monoamine oxidase inhibitor (trade name Nardil) used to treat clinical depression
tranylcypromine - an antidepressant drug that is a monoamine oxidase inhibitor; administered as a sulfate
Based on WordNet 3.0, Farlex clipart collection. © 2003-2012 Princeton University, Farlex Inc.
References in periodicals archive ?
In addition, in order to evaluate suspected alterations in the monoaminergic system, we investigated behavioral responses to tranylcypromine (Tcy), a monoamine oxidase inhibitor.
Monoamine oxidase inhibitors (MAOIs) have well-established efficacy for treating depression, panic disorder, and social phobia.
The antidepressants, mood lifting drugs, fall into three main groups: the tricyclics, the "atypical" (or second generation) group, and the monoamine oxidase inhibitors (MAOI).
Tyramine in foods and monoamine oxidase inhibitor drugs: a crossroad where medicine, nutrition, pharmacy, and food industry converge.
One patient was taking escitalopram and the monoamine oxidase inhibitor selegiline.
In a survey of psychiatrists with AIDS expertise, the top choices for first-line treatment of depression in patients with HIV who had not yet started antiretrovirals were desipramine, amitriptyline, fluvoxamine, or a monoamine oxidase inhibitor, Dr.
The agent is a selective monoamine oxidase inhibitor (MAOI).
In this scheme, the "classic combo" is an antidepressant plus lithium; the "hormone combo" is an antidepressant plus thyroid hormone; the "norepinephrine combo" is an SSRI plus a tricyclic; the "adrenergic combo" is a tricyclic plus bupropion or a stimulant; the "cautious combo" is a tricyclic plus a monoamine oxidase inhibitor (in that order); and the "serotonin combo" is an SSRI plus buspirone, mirtazapine (Remeron), or trazodone.
Transdermal selegiline may make it possible to achieve the antidepressant efficacy of a monoamine oxidase inhibitor without the dietary restrictions and acute hypertensive risks that have been largely responsible for the fall from favor of this drug class, Dr.
It should not be prescribed for patients with arteriosclerosis, symptomatic heart disease, moderate to severe hypertension, hyperthyroidism, seizures, glaucoma, agitated states, a history of substance abuse problems, a known allergy or unusual reactions to sympathomimetic amines, or for patients who have taken a monoamine oxidase inhibitor in the previous 14 days.
The recent approval of an irreversible monoamine oxidase inhibitor for treating Parkinson's disease includes an indication for patients with early disease as well as for those with more advanced disease who are already on levodopa.
The Food and Drug Administration's approval of a transdermal patch containing selegiline, an irreversible monoamine oxidase inhibitor, for treating major depression could bring much-needed help to the large population of patients that has not responded to uptake inhibitors.